Cannabinoid News

News related to the possible medical uses of cannabinoids

A new stance on CBD

The World Health Organization (WHO) announced months ago a different position on Cannabidiol   (CBD), one of the active cannabinoid chemicals in the marijuana plant. Research has shown CBD to have a range of properties that may be therapeutically useful. In 2018, an update critical review report (carried out by the Expert Committee of Drug Dependence) [...]

Legal Framework in the UK regarding use of Medical Cannabis

During the last year 2018, the legislation surrounding therapeutic Cannabis in the UK was in constant change, due to the need to help patients suffering from severe intractable epilepsy. Besides, Canada became the second country worldwide, after Uruguay, to legalise medical cannabis programs. What has triggered the legal modifications in the UK? The British online [...]

The DEA includes a cannabidiol-based medicine in the Controlled Substances Act

On Thursday 27th of September, Epidiolex became the first cannabidiol-based substance placed under Schedule V of the Controlled Substances Act (CSA) by the Department of Justice and Drug Enforcement Administration (DEA). This was the consequence of a large, controlled and successful clinical trial that led the DEA to accept the medical application of this CBD-based [...]

Canada legalises Cannabis

On the 17th of October, Canada became the second country worldwide, after Uruguay, to legalise cannabis. The legislature allows its open selling to the public but this one is regulated differently depending on the region. In some cases, its growing is allowed, but there exist cases, like Quebec and Manitoba, where growing the plant is [...]

Why are synthetic cannabinoids so dangerous?

40 years ago research began on the creation of synthetic cannabinoids to evluate their possible clinical use for diseases like multiple sclerosis and HIV/AIDS, as well as a palliative for people with cancer who are going through chemotherapy. The research was led by John Huffman and over the course of 20 years Huffman and his [...]

Kalapa Clinic will be present at the 2nd Cannabmed Congress in Barcelona

On 11th and 12th of May, the 2nd Cannabmed Congress will be held in Barcelona under the title "A bridge between medical cannabis and patients". This is a motto that reflects the objective of this unique meeting in Spain. The Congress is the only one in the country that focuses on the figure of the [...]

What is THCA?

The cannabis plant is made up of hundreds of components, known as cannbinoids, that each have their own therapeutic benefits. One of these components is tetrahydrocannabinolic acid, better known as THCA. It is the component of cannabis Sativa L, precursor of tetrahydrocannabinol (THC), one of the most abundant cannabinoids in the variety of cannabis plants. [...]

CBD as an antipsychotic

The World Health Organisation (WHO) estimates that there are around 51 million people worldwide who suffer from bipolar disorder, with almost the same amount suffering from schizophrenia. Antipsychotic medications that are currently available on the market to treat these types of conditions can have some very serious side effects, anything from dizziness and vomiting to [...]

Developing a consensus about medical cannabis-based therapies

The legal status of the cannabis plant has made it difficult for studies and investigations to demonstrate its beneficial properties to treat many pathologies. This has led to a lack of scientific review on the efficiency of cannabinoid therapy for cannabinoid use compared to other modes of consumption of the Cannabis Sativa L plant. For [...]

Cannabibiol has been taken off the WADA Prohibited Substances List

The World Anti-Doping Agency (WADA) announced that from the 1st of January 2018 Cannabidiol will no longer be on the prohibited substances list. WADA was established in 1999 as an international independent agency that focuses their efforts on scientific research, education, developing anti-doping techniques as well as creating (in 2004) monitoring the World Anti-Doping Code [...]

Our Services

CENTRAL OFFICE LOCATION

Kalapa Clinic S.L.
B66397506
Gran de Gràcia 15 , 1º.1ª
08012. Barcelona. Spain.
Tel: +34 630 109 176
Email: info@kalapa-clinic.com
Llamar a Kalapa Clinic